{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:42:47Z","timestamp":1791308567764,"version":"4.3.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD088393"],"award-info":[{"award-number":["R01HD088393"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the comparative pregnancy outcomes in women who receive up to six consecutive cycles of ovulation induction with letrozole versus clomiphene citrate?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The risks of pregnancy, livebirth, multiple gestation, preterm birth, neonatal intensive care unit (NICU) admission and congenital malformations were higher for letrozole compared with clomiphene in participants with polycystic ovarian syndrome (PCOS), though no treatment differences were observed in those with unexplained infertility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Randomized trials have reported higher pregnancy and livebirth rates for letrozole versus clomiphene among individuals with PCOS, but no differences among those with unexplained infertility. None of these trials were designed to study maternal or neonatal complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>We emulated a hypothetical trial of the comparative effectiveness of letrozole versus clomiphene citrate for ovulation induction among all women, then stratified by PCOS and unexplained infertility status. We used real-world data from a large healthcare claims database in the USA (2011\u20132015).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>We analyzed data from 18\u200a120 women who initiated letrozole and 49\u200a647 women who initiated clomiphene during 2011\u20132014, and who were aged 18\u201345 years with no history of diabetes, thyroid disease, liver disease or breast cancer and had no fertility treatments for 3 months before trial initiation. The treatment strategies were clomiphene citrate or letrozole for six consecutive cycles. The outcomes were pregnancy, livebirth, multiple gestation, preterm birth, small for gestational age (SGA), NICU admission and major congenital malformations. We estimated the probability of each outcome under each strategy via pooled logistic regression and used standardization to adjust for confounding and selection bias due to loss to follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The estimated probabilities of pregnancy, livebirth and neonatal outcomes were similar under each strategy, both overall and among individuals with unexplained infertility. Among women with PCOS, the probability of pregnancy was 43% for letrozole vs 37% for clomiphene (risk difference [RD] = 6.0%; 95% CI: 4.4, 7.7) in the intention-to-treat analyses. The corresponding probability of livebirth was 32% vs 29% (RD = 3.1%; 95% CI: 1.5, 4.8). In per protocol analyses, the risk of multiple gestation was 19% vs 9%, the risk of preterm birth was 20% vs 15%, the risk of SGA was 5% vs 3%, the risk of NICU admission was 22% vs 16% and the risk of congenital malformation was 8% vs 2% among those with a livebirth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>We cannot completely rule out the possibility of residual confounding by body mass index or duration of infertility. However, we adjusted for proxies identified in administrative data and results did not change.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Our findings suggest that for women with unexplained infertility, the two treatments result in comparable probabilities of a livebirth. For women with PCOS, letrozole appears slightly more effective for attaining a livebirth. Neonatal outcomes were similar for the two treatments among women with unexplained infertility; we did not confirm the hypothesized higher risk of adverse neonatal outcomes for clomiphene versus letrozole. The risks of adverse neonatal outcomes were slightly greater among women with PCOS who were treated with letrozole versus clomiphene. It is likely that these effects are partially mediated through an increased risk of multiple gestation among women who received letrozole.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was supported by the National Institute of Child Health and Human Development (R01HD088393). Y.-H.C. reports grants from the American Heart Association (834106) and NIH (R01HD097778). P.R. reports grants from the National Institutes of Health. J.H. reports grants from the National Institutes of Health, the Agency for Healthcare Research and Quality, and the California Health Care Foundation during the conduct of the study; and consulting for several health care delivery organizations including Cambridge Health Alliance, Columbia University, University of Southern California, Community Servings, and the Delta Health Alliance. S.H.-D. reports grants from the National Institutes of Health and the US Food and Drug Administration during the conduct of the study; grants to her institution from Takeda outside the submitted work; consulting for UCB (biopharmaceutical company) and Roche; and being an adviser for the Antipsychotics Pregnancy Registry and epidemiologist for the North American Antiepileptics Pregnancy Registry, both at Massachusetts General Hospital. M.A.H. reports grants from the National Institutes of Health and the U.S. Veterans Administration during the conduct of the study; being a consultant for Cytel; and being an adviser for ProPublica.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deac005","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T20:10:52Z","timestamp":1641499852000},"page":"793-805","source":"Crossref","is-referenced-by-count":22,"title":["Emulating a target trial of the comparative effectiveness of clomiphene citrate and letrozole for ovulation induction"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-8971","authenticated-orcid":false,"given":"Jennifer J","family":"Yland","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Han","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rinaudo","sequence":"additional","affiliation":[{"name":"Center for Reproductive Health, University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hsu","sequence":"additional","affiliation":[{"name":"Mongan Institute, Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Health Care Policy, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Hern\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-7642","authenticated-orcid":false,"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA"},{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"2022040313210949600_deac005-B1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jog.13644","article-title":"Comparison of the pregnancy outcomes and the incidence of fetal congenital abnormalities in infertile women treated with letrozole and clomiphene citrate","volume":"44","author":"Akbari Sene","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"2022040313210949600_deac005-B2","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer","year":"2017","journal-title":"Hum Reprod"},{"key":"2022040313210949600_deac005-B3","first-page":"347","article-title":"ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 34, February 2002. Management of infertility caused by ovulatory dysfunction. American College of Obstetricians and Gynecologists","volume":"99","author":"American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2022040313210949600_deac005-B4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.fertnstert.2019.10.014","article-title":"Evidence-based treatments for couples with unexplained infertility: a guideline","volume":"113","author":"American Society for Reproductive Medicine","year":"2020","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10815-013-9980-6","article-title":"What is the best treatment option for infertile women aged 40 and over?","volume":"30","author":"Armstrong","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2022040313210949600_deac005-B6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/1471-0528.15800","article-title":"Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies","volume":"126","author":"Auffret","year":"2019","journal-title":"BJOG"},{"key":"2022040313210949600_deac005-B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00016340802638199","article-title":"Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility","volume":"88","author":"Badawy","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2022040313210949600_deac005-B8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00404-011-2091-7","article-title":"Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome","volume":"285","author":"Banerjee Ray","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"2022040313210949600_deac005-B9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00404-008-0714-4","article-title":"Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery doppler","volume":"279","author":"Baruah","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"2022040313210949600_deac005-B10","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/jc.2005-1923","article-title":"Aromatase inhibitors for ovulation induction","volume":"91","author":"Casper","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2022040313210949600_deac005-B12","volume-title":"2018 Assisted Reproductive Technology Fertility Clinic Success Rates Report","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2022040313210949600_deac005-B13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/pds.1534","article-title":"Positive predictive value of computerized records for major congenital malformations","volume":"17","author":"Cooper","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022040313210949600_deac005-B14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"2022040313210949600_deac005-B15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/AOG.0000000000003105","article-title":"Letrozole compared with clomiphene citrate for unexplained infertility: a systematic review and meta-analysis","volume":"133","author":"Eskew","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2022040313210949600_deac005-B16","first-page":"CD010287","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2022040313210949600_deac005-B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006250-197803000-00002","article-title":"Ovulation and pregnancy rates with clomiphene citrate","volume":"51","author":"Gorlitsky","year":"1978","journal-title":"Obstet Gynecol"},{"key":"2022040313210949600_deac005-B18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(16)57905-9","article-title":"Clomiphene citrate and neural tube defects: a pooled analysis of controlled epidemiologic studies and recommendations for future studies","volume":"64","author":"Greenland","year":"1995","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2022040313210949600_deac005-B20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2022040313210949600_deac005-B21","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/humrep\/dei042","article-title":"Clomiphene citrate\u2014end of an era? A mini-review","volume":"20","author":"Homburg","year":"2005","journal-title":"Hum Reprod"},{"key":"2022040313210949600_deac005-B22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2018.01.008","article-title":"Ovarian stimulation in infertile women treated with the use of intrauterine insemination: a cohort study from china","volume":"109","author":"Huang","year":"2018","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.fertnstert.2008.10.009","article-title":"Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women","volume":"93","author":"Jirge","year":"2010","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B25","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.fertnstert.2010.06.008","article-title":"Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial","volume":"94","author":"Kamath","year":"2010","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"2022040313210949600_deac005-B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"2022040313210949600_deac005-B28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/pds.3407","article-title":"Validation of an algorithm to estimate gestational age in electronic health plan databases","volume":"22","author":"Li","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022040313210949600_deac005-B29","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","article-title":"Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial","volume":"33","author":"Liu","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2022040313210949600_deac005-B30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.2047-2927.2013.00110.x","article-title":"The prevalence of couple infertility in the United States from a male perspective: evidence from a nationally representative sample","volume":"1","author":"Louis","year":"2013","journal-title":"Andrology"},{"key":"2022040313210949600_deac005-B31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ppe.12459","article-title":"Assessment of recording bias in pregnancy studies using health care databases: an application to neurologic conditions","volume":"32","author":"MacDonald","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2022040313210949600_deac005-B32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022040313210949600_deac005-B33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bdra.20243","article-title":"Clomiphene and hypospadias on a detailed level: signal or chance?","volume":"76","author":"Meijer","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2022040313210949600_deac005-B34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2004.08.013","article-title":"Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation","volume":"192","author":"Mitwally","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2022040313210949600_deac005-B35","volume-title":"Ovulation Disorders Fertility: Assessment and Treatment for People with Fertility Problems","author":"National Collaborating Centre for Women's and Children's Health (UK)","year":"2004"},{"key":"2022040313210949600_deac005-B36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/pds.3627","article-title":"Validity of maternal and infant outcomes within nationwide medicaid data","volume":"23","author":"Palmsten","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022040313210949600_deac005-B37","doi-asserted-by":"crossref","first-page":"e67405","DOI":"10.1371\/journal.pone.0067405","article-title":"Harnessing the medicaid analytic extract (max) to evaluate medications in pregnancy: design considerations","volume":"8","author":"Palmsten","year":"2013","journal-title":"PLoS One"},{"key":"2022040313210949600_deac005-B38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/pds.3740","article-title":"Accuracy of ICD-9-CM coding to identify small for gestational age newborns","volume":"24","author":"Phiri","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022040313210949600_deac005-B39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0015-0282(16)54473-2","article-title":"Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles","volume":"56","author":"Randall","year":"1991","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/deq313","article-title":"Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997\u20132005","volume":"26","author":"Reefhuis","year":"2010","journal-title":"Hum Reprod"},{"key":"2022040313210949600_deac005-B41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-1208.97789","article-title":"A prospective randomized trial comparing the efficacy of letrozole and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome","volume":"5","author":"Roy","year":"2012","journal-title":"J Hum Reprod Sci"},{"key":"2022040313210949600_deac005-B42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00404-008-0888-9","article-title":"Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate","volume":"280","author":"Samani","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"2022040313210949600_deac005-B43","doi-asserted-by":"crossref","first-page":"e108219","DOI":"10.1371\/journal.pone.0108219","article-title":"Congenital malformations among babies born following letrozole or clomiphene for infertility treatment","volume":"9","author":"Sharma","year":"2014","journal-title":"PLoS One"},{"key":"2022040313210949600_deac005-B44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bmj.38326.606979.79","article-title":"Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study","volume":"330","author":"S\u00f8rensen","year":"2005","journal-title":"BMJ"},{"key":"2022040313210949600_deac005-B45","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.fertnstert.2012.11.037","article-title":"Prevalence of infertility in the united states as estimated by the current duration approach and a traditional constructed approach","volume":"99","author":"Thoma","year":"2013","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B46","author":"US Food and Drug Administration. Drugs@FDA: FDA Approved Drug Products","year":"1967"},{"key":"2022040313210949600_deac005-B47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0015-0282(16)49209-5","article-title":"The reproductive toxicity of ovulation induction","volume":"45","author":"Wallach","year":"1986","journal-title":"Fertil Steril"},{"key":"2022040313210949600_deac005-B48","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/09513590.2019.1612358","article-title":"Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome: a randomized controlled study","volume":"35","author":"Wang","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2022040313210949600_deac005-B49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/bdra.20313","article-title":"Potential association between infertility and spinal neural tube defects in offspring","volume":"76","author":"Wu","year":"2006","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2022040313210949600_deac005-B50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.reprotox.2018.10.006","article-title":"Comparison of congenital malformations among babies born after administration of letrozole or clomiphene citrate for infertility treatment in a Korean cohort","volume":"82","author":"Yun","year":"2018","journal-title":"Reprod Toxicol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/4\/793\/43247049\/deac005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/4\/793\/43247049\/deac005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:21:42Z","timestamp":1648992102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/4\/793\/6511990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,1,20]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac005","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2022,1,20]]}}}